Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16953010 | 0.85 | TSHR (0.31) | TSHRKDM4EALDH1A1 | |
| SCHEMBL16960095 | 0.85 | TSHR (0.35) | TSHRKDM4EALDH1A1MCL1 | |
| SCHEMBL1191251 | 0.74 | — | — | |
| SCHEMBL350376 | 0.74 | — | — | |
| SCHEMBL979388 | 0.74 | — | — | |
| SCHEMBL351061 | 0.74 | — | — | |
| SCHEMBL8882005 | 0.74 | — | — | |
| SCHEMBL16955460 | 0.74 | — | — | |
| SCHEMBL351330 | 0.74 | — | — | |
| SCHEMBL979387 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110386923-B | Carbazole compound, application thereof and organic electroluminescent device | 北京鼎材科技有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-110396081-B | Heterocyclic compound based on carbazole and fluorene, application thereof and organic electroluminescent device | 北京鼎材科技有限公司 | 2021-12-31 | — | — | CN | claimed |
| CN-112480177-A | Luminescent diaza-, monoaza-and benzo-imidazole metal carbene complexes for use in electronic devices and methods for their preparation | UDC 爱尔兰有限责任公司 | 2021-03-12 | — | — | CN | claimed |
| CN-111825660-A | Compound, thermal activation delayed fluorescence material, organic electroluminescent device and application | 北京鼎材科技有限公司 | 2020-10-27 | — | — | CN | claimed |
| CN-111320607-A | Organic compound with triphenylene-containing polycyclic heteroaromatic group as core and application thereof | 机光科技股份有限公司 | 2020-06-23 | — | — | CN | claimed |
| US-20200125564-A1 | NOVEL NK-3 RECEPTOR SELECTIVE ANTAGONIST COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN NK-3 RECEPTORS MEDIATED DISORDERS | OGEDA SA (BE) | 2020-04-23 | — | — | US | claimed |
| US-10544150-B2 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | OGEDA SA (BE) | 2020-01-28 | — | — | US | claimed |
| US-10290817-B2 | Luminescent diaza-monoaza-and benzimidazole metal carbene complexes for use in electronic devices such as OLEDs | UDC IRELAND LIMITED (IE) | 2019-05-14 | — | — | US | claimed |
| US-10087541-B2 | Method of forming a dielectric through electrodeposition on an electrode for a capacitor | UNIVERSITY OF TARTU (EE) | 2018-10-02 | — | — | US | claimed |
| US-10065960-B2 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | OGEDA SA (BE) | 2018-09-04 | — | — | US | claimed |
| WO-2004089888-A1 | PYRAZOLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2004-10-21 | — | — | WO | claimed |
| WO-2004089931-A1 | SUBSTITUTED PYRAZOLES | MERCK PATENT GMBH (DE) | 2004-10-21 | — | — | WO | claimed |
| WO-2004089932-A1 | SUBSTITUTED PYRAZOLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2004-10-21 | — | — | WO | claimed |
| WO-2004089910-A1 | 1,3,4-SUBSTITUTED PYRAZOLES FOR USE AS 5-HT RECEPTOR ANTAGONISTS IN THE TREATMENT OF PSYCHOSES AND NEUROLOGICAL DISORDERS | MERCK PATENT GMBH (DE) | 2004-10-21 | — | — | WO | claimed |
| WO-2004072087-A2 | METAL COMPLEXES AS LIGHT-ABSORBING COMPOUNDS IN THE INFORMATION LAYER OF OPTICAL DATA CARRIERS | LANXESS DEUTSCHLAND GMBH (DE) | 2004-08-26 | — | — | WO | claimed |
| EP-1419128-A1 | IMPROVED HYDROLYTIC KINETIC RESOLUTION OF EPOXIDES | Rhodia Pharma Solution Inc., (formally Rhodia Chirex Inc.) (US) | 2004-05-19 | — | — | EP | claimed |
| US-6693206-B2 | USING COBALT COMPLEX CATALYST | RHODIA CHIREX, INC. | 2004-02-17 | — | — | US | claimed |
| US-20030073855-A1 | Hydrolytic kinetic resolution of epoxides | RHODIA CHIREX, INC. | 2003-04-17 | — | — | US | claimed |
| WO-2003018520-A1 | IMPROVED HYDROLYTIC KINETIC RESOLUTION OF EPOXIDES | RHODIA PHARMA SOLUTIONS INC. (US) | 2003-03-06 | — | — | WO | claimed |
| US-4293306-A | Process for the dyeing and printing of hydrophobic synthetic organic fiber materials with water-insoluble azo dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-10-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10065960-B2 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | BDKRB2, ACKR3, KLRK1 | TSHR 477/4885KDM4E 3829/4885ALDH1A1 3468/4885 |
| US-10290817-B2 | Luminescent diaza-monoaza-and benzimidazole metal carbene complexes for use in electronic devices such as OLEDs | OCIAD1, OCIAD2, OXA1L | TSHR 3295/4885KDM4E 2664/4885ALDH1A1 857/4885 |
| US-20030073855-A1 | Hydrolytic kinetic resolution of epoxides | EPHX2, EPHX1, POR | TSHR 4250/4885KDM4E 443/4885ALDH1A1 325/4885 |
| US-10544150-B2 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | BDKRB2, ACKR3, KLRK1 | TSHR 477/4885KDM4E 3829/4885ALDH1A1 3468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.